CREDIT SUISSE AG/ - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 56 filers reported holding CARA THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$439,961
-52.9%
89,605
+3.0%
0.00%
-100.0%
Q4 2022$934,755
+108.7%
87,035
+81.7%
0.00%
Q3 2022$448,000
+3.0%
47,901
+0.6%
0.00%
Q2 2022$435,000
-27.0%
47,636
-2.9%
0.00%
-100.0%
Q1 2022$596,000
-1.5%
49,079
-1.1%
0.00%
Q4 2021$605,000
-12.8%
49,625
+10.6%
0.00%
Q3 2021$694,000
-1.1%
44,879
-8.8%
0.00%
Q2 2021$702,000
-20.4%
49,233
+21.1%
0.00%
Q1 2021$882,000
+16.8%
40,667
-18.5%
0.00%
Q4 2020$755,000
+75.2%
49,878
+47.1%
0.00%
Q3 2020$431,000
-32.1%
33,904
-8.7%
0.00%
Q2 2020$635,000
+105.5%
37,148
+58.8%
0.00%
Q1 2020$309,000
-28.6%
23,392
-13.0%
0.00%
Q4 2019$433,000
-11.1%
26,892
+0.9%
0.00%
Q3 2019$487,000
+19.4%
26,643
+40.2%
0.00%
Q2 2019$408,000
-9.9%
19,004
-17.5%
0.00%
Q1 2019$453,000
+32.1%
23,046
-12.8%
0.00%
Q4 2018$343,000
-21.0%
26,425
+46.1%
0.00%
Q3 2018$434,000
-6.9%
18,092
-25.6%
0.00%
Q2 2018$466,000
+23.6%
24,308
-20.1%
0.00%
Q1 2018$377,000
-50.6%
30,408
-51.2%
0.00%
-100.0%
Q4 2017$763,000
+11.1%
62,363
+24.5%
0.00%0.0%
Q3 2017$687,000
-50.5%
50,084
-44.5%
0.00%0.0%
Q2 2017$1,389,000
+857.9%
90,246
+476.9%
0.00%
Q4 2016$145,000
+5.1%
15,644
-5.2%
0.00%
Q3 2016$138,000
+10.4%
16,497
-36.8%
0.00%
Q2 2016$125,000
+5.9%
26,118
+38.1%
0.00%
Q1 2016$118,000
-17.5%
18,915
+88.8%
0.00%
Q3 2015$143,000
-57.1%
10,018
-63.4%
0.00%
Q2 2015$333,000
+34.8%
27,402
+11.4%
0.00%
Q1 2015$247,000
+48.8%
24,602
+23.8%
0.00%
Q3 2014$166,00019,8720.00%
Other shareholders
CARA THERAPEUTICS INC shareholders Q3 2014
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 3,568,057$70,005,00074.08%
Chescapmanager LLC 1,203,055$23,604,0002.80%
Mesirow Financial Investment Management, Inc. 29,821$585,0002.32%
DAFNA Capital Management LLC 143,611$2,818,0001.22%
Opaleye Management Inc. 200,000$3,924,0001.09%
SPHERA FUNDS MANAGEMENT LTD. 303,930$5,963,0000.54%
DISCIPLINED GROWTH INVESTORS INC /MN 852,892$16,734,0000.29%
DLD Asset Management, LP 352,700$6,927,0000.26%
SHANDA ASSET MANAGEMENT HOLDINGS Ltd 54,984$1,079,0000.18%
B. Riley Wealth Management, Inc. 33,755$662,0000.12%
View complete list of CARA THERAPEUTICS INC shareholders